{"article": [{"url": "https://www.marketwatch.com/story/british-american-tobacco-says-its-awaiting-fda-permission-to-start-covid-19-vaccine-trials-2020-07-31", "published": 1596164900.0, "headline": "British American Tobacco says it's awaiting FDA permission to start COVID-19 vaccine trials", "body": "British American Tobacco's BATS, -0.73% BTI, -0.17% Kentucky BioProcessing division has applied and is awaiting U.S. Food and Drug Administration approval to start a trial of its COVID-19 vaccine, said Kingsley Wheaton, the company's chief marketing officer, in an interview with MarketWatch. He said that approval to begin testing could be \"pretty imminent.\" The unit already has FDA approval to test an influenza vaccine. British American Tobacco had announced in April that it was trying to create a COVID-19 vaccine and that its work there would be on a not-for-profit basis."}]}